Zealand Pharma A/S ROE 2018-2022 | ZEAL

Current and historical return on equity (ROE) values for Zealand Pharma A/S (ZEAL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2022-03-31 $-0.16B $0.11B -94.01%
2021-12-31 $-0.16B $0.15B -77.98%
2021-09-30 $-0.18B $0.19B -81.75%
2021-06-30 $-0.18B $0.23B -78.03%
2021-03-31 $-0.14B $0.27B -58.73%
2020-12-31 $-0.13B $0.19B -59.28%
2020-09-30 $-0.10B $0.25B -45.80%
2020-06-30 $-0.08B $0.27B -38.95%
2020-03-31 $-0.09B $0.18B -52.08%
2019-12-31 $-0.09B $0.19B -48.66%
2019-09-30 $-0.07B $0.21B -42.90%
2019-06-30 $0.09B $0.15B 51.63%
2019-03-31 $0.09B $0.17B 60.79%
2018-12-31 $0.09B $0.17B 75.72%
2018-09-30 $0.09B $0.19B 92.70%
2018-06-30 $-0.06B $0.05B -77.63%
2018-03-31 $-0.05B $0.07B -75.71%
2017-12-31 $-0.04B $0.08B -68.85%